Shifting paradigms & advancing technology to find I–O biomarkers
Immuno-Oncology Insights 2022; 3(11), 547–551
Abigail Pinchbeck, Assistant Editor, BioInsights, speaks to Mustafa Khasraw, Deputy Director of the Center for Cancer Immunotherapy, Duke Cancer Institute
The discovery of relevant biomarkers in immuno-oncology is crucial to match the right patients to the right treatments. In this interview, Mustafa Khasraw, Deputy Director of the Center for Cancer Immunotherapy at the Duke Cancer Institute, highlights the current challenges in this space – and potential approaches to overcome them.